Fact Check: Ivermectin Is NOT An Approved Or Proven Cancer Treatment

Fact Check

  • by: Ed Payne

STORY UPDATED: check for updates below.

Fact Check: Ivermectin Is NOT An Approved Or Proven Cancer Treatment Not Authorized

Is ivermectin a more effective cancer treatment than chemotherapy? No, that's not true: The Food and Drug Administration says ivermectin is approved to treat parasitic worms, head lice and skin conditions like rosacea, but does not list it as a treatment for cancer. The National Cancer Institute told Lead Stories that it has no information "supporting the claim" about ivermectin as a cancer treatment.

The claim appeared in a post on Threads on October 22, 2024. The post's caption said:

Ivermectin is proving more effective then chemotherapy in treating cancer. Who knew? Ivermectin cost almost nothing and helps in many different ways.

This is what the post looked like on Threads at the time of writing:

chrome_fweRqULSDo.png

(Source: Threads screenshot taken on Tue Oct 29 18:24:32 2024 UTC)

The post provided no evidence to support its assertion that ivermectin is a more effective cancer treatment than chemotherapy.

Food and Drug Administration

In an October 30, 2024, email to Lead Stories, a Food and Drug Administration (FDA) spokesperson said, "Ivermectin is not currently FDA-approved for the treatment of cancer." They continued:

Ivermectin tablets are approved by the FDA to treat people with intestinal strongyloidiasis and onchocerciasis, two conditions caused by parasitic worms. In addition, some topical forms of ivermectin are approved to treat external parasites like head lice and for skin conditions such as rosacea.

Among its many functions, the FDA regulates human and veterinary drugs, biological products and medical devices in the United States.

National Cancer Institute

When asked about the social media post suggesting that ivermectin is a more effective cancer treatment than chemotherapy, the National Cancer Institute (NCI) provided this response to Lead Stories in an email on October 29, 2024. The statement from the NCI Media Office said:

The National Cancer Institute, a component of the National Institutes of Health, disseminates evidence-based, scientifically accurate information about cancer to the public. It does not appear from a search of our resources that the NCI maintains any information supporting the claim.

Read more

At the time this was written, a similar claim had previously been reviewed by AP News in 2023.

Additional Lead Stories fact checks of claims involving ivermectin are available here.

Updates:

  • 2024-10-30T14:33:06Z 2024-10-30T14:33:06Z
    Adds context from an FDA spokesperson.

Want to inform others about the accuracy of this story?

See who is sharing it (it might even be your friends...) and leave the link in the comments.:


  Ed Payne

Ed Payne is a staff writer at Lead Stories. He is an Emmy Award-winning journalist as part of CNN’s coverage of 9/11. Ed worked at CNN for nearly 24 years with the CNN Radio Network and CNN Digital. Most recently, he was a Digital Senior Producer for Gray Television’s Digital Content Center, the company’s digital news hub for 100+ TV stations. Ed also worked as a writer and editor for WebMD. In addition to his journalistic endeavors, Ed is the author of two children’s book series: “The Daily Rounds of a Hound” and “Vail’s Tales.” 

Read more about or contact Ed Payne

About Us

International Fact-Checking Organization EFCSN Meta Third-Party Fact Checker

Lead Stories is a fact checking website that is always looking for the latest false, misleading, deceptive or inaccurate stories, videos or images going viral on the internet.
Spotted something? Let us know!.

Lead Stories is a:


WhatsApp Tipline

Have a tip or a question? Chat with our friendly robots on WhatsApp!

Add our number +1 (404) 655-4223, follow this link or scan the image below with your phone:

@leadstories

Subscribe to our newsletter

* indicates required

Please select all the ways you would like to hear from Lead Stories LLC:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Most Read

Most Recent

Share your opinion